JNJ-40929837 | Interleukin Related interleukin-related.com

Product Name :
JNJ-40929837

Search keywords :
JNJ-40929837

drugId :
null

Target Vo:
Leukotriene A-4 hydrolase

Target Vo Short Name :
LTA4

Moa_Name:
Leukotriene A-4 hydrolase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Asthma

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HDAC10 Antibody
NFAT2 Antibody
Phospho-eIF2A (Ser51) Antibody: Phospho-eIF2A (Ser51) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-eIF2A (Ser51). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts